Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective anticoagulation with factor xA next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48) - Ruff, C T; Giugliano, R P; Antman, E M (Am Heart J, 2010)
et al.